Methods of Producing Pseudoscent Compositions of Narcotic Materials and Compositions Thereof

• US 20140311218A1
• Filed: 03/17/2014
• Published: 10/23/2014
• Est. Priority Date: 03/15/2013
• Status: Abandoned Application

• Current Assignee: David Adebimpe
• Original Assignee: David Adebimpe
• Inventors: Adebimpe, David
• Application Number:
  US14/217,431
• Publication Number:
  US 20140311218A1
• Time in Patent Office: Days
• US Class Current: 73/23.34
• CPC Class Codes: C07D 489/00 Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Abstract

This invention relates to a method that can be used to scientifically fabricate pseudoscents of narcotics, which, in their entirety, are comprised of non-narcotic materials. It also discloses specific compositions of such pseudoscents, which can be used as narcotic-free-but-odoriferously-identical simulants for a range of narcotics and are comprised of non-narcotic components of the scent signature of a narcotic and/or scent components of the same headspace scent signature that have narcotic qualities but have been rendered non-narcotic. The scents achievable by the groups of formulations generated by this method include the different types of prohibited and controlled narcotics, and the components within the pseudoscents can be further tuned to generate simulants representative of different qualities and quantities of such narcotics. These non-narcotic scent simulants can be used to bolster existing narcotic detector-dog training programs, establish new training paradigms in canine, rodent, insect, and other creature narcotic detection and training and, in some cases, increase the efficiencies of analytical instruments that rely on the phenomenon of vapor sampling to detect narcotic materials.

Claims

1. A method for producing an non-narcotic pseudoscent of a narcotic, the method comprising:

a) Targeting a narcotic material for detection;

b) Identifying the non-narcotic components of the scent signature of the narcotic material that is targeted for detection;

c) Substituting the narcotic components within the scent signature of the narcotic material targeted for detection with non-narcotic components that are odoriferously similar to the narcotic components within such scent signature by replacing one or more of such narcotic components with a non-narcotic replacement that has similar electronic properties but are non-narcotic in character; and

d) Combining components identified in b) into a first formulation,

e) Combining the components identified in c) into a second formulation to form a non-narcotic pseudoscent wherein the non-narcotic pseudoscent is free of the narcotic.

2. The method of claim 1, further comprising combining the non-narcotic components of the scent signature of the first formulation with the second formulation to form a composite non-narcotic formulation.

3. The method of claim 1, wherein the non-narcotic replacement of the scent signature is selected from a narcotic component from the scent signature of the narcotic material.

4. The method of claim 3, wherein the narcotic component of the scent signature of the narcotic material is replaced with a non-narcotic equivalent successively by replacing the functional groups within the molecular structure of the narcotic component of the scent signature with functional groups that have similar electronic properties.

5. The method of claim 3, wherein the narcotic component of the scent signature of the narcotic material is replaced with a non-narcotic equivalent by replacing the molecular structural backbone of the narcotic component with a structural homologue that has similar electronic properties.

6. The method of claim 4, wherein electron withdrawing functional groups within the molecular structure of the narcotic component of the scent signature are replaced with functional groups with similar electron withdrawing properties

7. The method of claim 4, wherein electron-donating functional groups within the molecular structure of the narcotic component of the scent signature are replaced with functional groups with similar electron donating properties

8. The method of claim 6, wherein the electron-withdrawing replacement functional group is selected from the group consisting of cyano, acetyl, halogen, nitro, aldehyde, and carboxylic acid functional groups.

9. The method of claim 7, wherein the electron-donating replacement functional group is selected from the group consisting of amino, hydroxyl, alkoxy, halogen, aryl, and alkyl functional groups.

10. The method of claim 1, wherein the narcotic material is selected from the group consisting of cocaine, crack cocaine, K2 (spice), heroin, methamphetamines, amphetamines, methylenedioxymethamphetamines (MDMA), cannabis, ergoline, morphine, thebaine, synthetic cannabinoids, opium, lysergic acid diethylamide (LSD), hashish, and PCP.

11. The method of claim 1, wherein the non-narcotic components are selected from the group consisting of phenylacetic acid, cryophyllene, piperonal, cinnamic acid, benzodioxole, myrcene, propiophenone, butoxyethanol, terpineol, pyrrolidine, propyl benzoate, bis(hexamethylene)triamine, benzaldehyde, aminophenyl butane, benzylmethylamine, pinene, carene, limoline, aminophenylbutane, phenyl acetate, quinoline, hydroxyphenylacetic acid, methybenzylacetate, dipropylamine, diethylacetamide, acetylphenol, benzylideneacetone, isosafrole, ethyl acetate, hydroxyacetophenone, methyl cinnamate, propyl acetate, benzoic acid, phenylcyclohexene, methylenedioxyphenylacetic acid, water, and dimethylfornamide.

12. The method of claim 2, further comprising dissolving the first, second, or composite formulations in a solvent, adding an inert matrix, and removing the solvent.

13. The method of claim 2, wherein the second formulation is selected from the group consisting of phenylacetic acid, piperonal, isosafrole, benzodioxole, myrcene, pinene, cryophyllene, propiophenone, benzaldehyde, water, aminophenyl butane, N-Benzylmethylamine, aminophenylbutane, phenyl acetate, 2-hydroxyacetophenone, butoxyl ethanol, methyl cinnamate, propyl acetate, cinnamic acid, benzoic acid, 1-phenylcyclohexene, and dimethylfornamide.

14. The method of claim 1, further comprising compounding the first formulation, the second formulation, or the composite formulations with a chemically inert polymeric binder or dispersant with a molecular weight of ≧

320 atomic mass units (a.m.u.).

15. The method of claim 1, further comprising absorbing the first formulation, the second formulation, or the composite formulations into a chemically inert porous supporting matrix material.

17. The method of claim 1, further comprising mixing the first formulation, the second formulation, or the composite formulation with a gelling agent to form a gel.

18. The method of claim 2, further comprising mixing the first formulation or the composite formulation to form an emulsion.

16. The method of 1, further comprising absorbing the first formulation, the second formulation, or the composite formulations onto grain husks, cellulose and natural fibers.

19. A method for producing a non-narcotic pseudoscent composition of a narcotic, the method comprising:

a. Identifying the non-narcotic components within the headspace scent signature of the narcotic material;

b. Selecting all or some of the identified non-narcotic components for combining into a formulation;

c. Combining non-narcotic components that are selected as odoriferously identical to the components of the headspace scent signature into a second formulation, wherein the non-narcotic pseudoscent is free of narcotics.

20. The composition of claim 19, wherein the non-narcotic components are selected from the group consisting of phenylacetic acid, piperonal, isosafrole, benzodioxole, myrcene, pinene, cryophyllene, propiophenone, benzaldehyde, aminophenyl butane, Benylmethylamine, aminophenyl butane, phenyl acetate, ethy benzoate, cyclohexylpiperidine, hydroxyacetophenone, butoxyl ethanol, water, methyl cinnamate, propyl acetate, cinnamic acid, benzoic acid, and phenylcyclohexene.

21. A method of evaluating a non-narcotic pseudoscent of a narcotic by exposing an effective amount of a non-narcotic pseuodoscent to a creature that is certified in a narcotics detection program that uses real narcotics in its training process.

22. The method of claim 22, wherein the creature is selected from the group consisting a bee, dog, and insect.